Trial
NCT01097707
A Study in Men With Benign Prostatic Hyperplasia
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Benign Prostatic Hyperplasia
Intervention
LY500307
Why stopped
Terminated due to insufficient efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-08